METASTATIC HEAD AND NECK CANCER
Clinical trials for METASTATIC HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough head and neck cancer
Disease control OngoingThis study tests whether adding ramucirumab to pembrolizumab works better than pembrolizumab alone for people with advanced head and neck cancer that has come back or spread. About 37 adults with PD-L1 positive cancer will take part. The goal is to see if the combination shrinks …
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New combo therapy aims to boost survival in hard-to-treat head and neck cancer
Disease control OngoingThis phase 3 study tests whether adding an experimental immunotherapy (PDS0101) to standard pembrolizumab helps people with advanced HPV16-positive head and neck cancer live longer or delay tumor growth. About 252 adults whose cancer has spread or returned and cannot be removed b…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: PHASE3 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Blood test may predict immunotherapy success in lung and Head/Neck cancers
Knowledge-focused OngoingThis study looks at how well immunotherapy works in patients with advanced lung or head/neck cancer. Researchers will measure how fast the drug leaves the body and track tumor cells in the blood. The goal is to find better ways to predict which patients will benefit from treatmen…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 17, 2026 07:05 UTC